High-Performance Liquid Chromatographic Determination of SAZ-VII-23, A Novel Antiarrhythmic Agent,in Dog Plasma and Urine

Abstract

A HPLC method has been developed to determine the concentrations of SAZ-VII-23 (3-benzoyl-7-isopropyl-3,7-diazabicyclo[3.3.1]nonane HClO₄), a novel antiarrhythmic agent, in dog plasma and urine. Plasma treated with acetonitrile and alkalinized urine were extracted with chloroform- propanol (9:1). An aliquot was injected on to HPLC system using a C₆ reversed-phase column and acetonitrile-methanol-37.5 mM phosphate buffer, pH 6.8 (28.5:28.5:43 v/v) containing 4.0 mM triethylamine as mobile phase. Detection wavelength was 255 nm. The linear range were 0.04–8 μg/ml, and the lower limit of quantitation was 0.04 μg/ml in plasma and urine, respectively. The method was applied to determine plasma and urine concentrations and preliminary pharmacokinetic profiles of SAZ-VII-23 in a dog.     

Separation and Quantitation of Urinary Phthalates by HPLC

Abstract

A method was developed for the separation and quantitation of plasticizers and their metabolites from human urine using HPLC, Urine was diluted with an equal volume of water and extracted at pH 2.0 with diethyl ether, The extract was dried, the solvent vacuum stripped, and the residue dissolved in methanol for injection into the chromatograph. A C₁₈ reverse phase column containing 10 μ particles was used for the analysis. Ionic suppression, 0.5% acetic acid in water, at pH 3.0 was used to resolve the acidic components. A step gradient of acetonitri1e:water (containing acetic acid) was used to elute the polar metabolites as well as the non-polar plasticizers. Mass spectrometry was used t o identify the compounds in the HPLC fractions. From the HPLC fractions of the urine extract collected, phthalic acid, MEHP, DEHP and normal urinary constituents (e.g., hippuric and benzoic acid derivatives) were identified     

Recycling HPLC of p-Bromophenacyl Esters of Saturated C35–56 Fatty Acids from Mycobacterium Tuberculosis H37Ra on a Silica Column

Abstract

The p-bromophenacyl esters of saturated C_35–56 fatty acids from Mycobacterium tuberculosis H37Ra were separated according to structural classes on a silica column by high performance liquid chromatography (HPLC). The sample was cycled five times during HPLC. Highly purified C_35–38 esters were obtained by this method. Further HPLC fractionation on a reverse-phase column (C₁₈-bonded silica) gave complete separation of most of the remaining fractions. By combining mass spectrometry with HPLC separations, many of the fatty acid esters were tentatively identified.     

High Pressure Liquid Chromatographic Assay for Salicylic Acid and its Metabolites in Rat Urine

Abstract

An HPLC method for the determination of salicylic acid (SA), gentisic acid (GA), salicyluric acid (SU), and salicyl acyl glucuronide (SAG) in rat urine was developed. The method consisted of extracting SA, GA, and SU from acidified urine into 50:50 mixture of ethyl acetate and butyl chloride. Salicyl acyl glucuronide was extracted from neutral urine after conversion to salicyl hydroxamic acid with hydroxylamine. Salicyl phenolic glucuronide was estimated indirectly as the difference between total salicylate and sum of the four constituents mentioned above. Chromatographic separation was done on a C₁₈ column with U.V. detection at 310 nm using a mobile phase consisting of 5–10% acetonitrile in 3% glacial acetic acid. The extraction recovery of these compounds from spiked urine ranged from 90–108%. The detection limits were 10 μg/ml for GA, SU and SA, and 2.5 μg/ml for SHA. The method was applied to the study of salicylic acid metabolism in the rat.     

Studies on Steroids CCXXXXIV. Separation and Characterization of C-25 Epimers of Unconjugated and Conjugated Trihydroxycholestanoic Acids in Urine from a Patient with Zell Weger Syndrome by High-Performance Liquid Chromatography

Abstract

The separation and characterization of C-25 epimers of unconjugated and glycine- and taurine-conjugated 3α, 7α, 12α - trihydroxy-5β-cholestanoic acid (THCA) in biological fluids by high-performance liquid chromatography (HPLC) are described. The 5β-cholestanoic acid fraction was obtained from a urine specimen from a patient with Zellweger syndrome by passing it through a Sep-pak C₁₈ cartridge. Bile acids were derivatized quantitatively into the fluorescent compounds through the hydroxyl group at C-3 by treatment with 1-anthroyl nitrile. The derivatives were separated into the unconjugated, glycine- and taurine-conjugated fractions by ion-exchange chromatography on alipophilicgel, piperidinohydroxypropyl Sephadex LH-20. Sub-sequent resolution of each fractionin to (25s)- and (25R)-THCA was attained by HPLC on a Cosmosil 5C column. The C-25 epimers of unconjugated and conjugated Tk%A were unequivocally identified on the b asis of the irbehaviors in HPLC using mobile phases of different pHs. The ratios of the unconjugated, glycine- and taurine-conjugated (25RbTHCA to the corresponding (25S)-epimers were 16:1, 5:4 and 3:2, respectively .     

Liquid Chromatographic Determination of 4-Amino-N-(2,6-dimethylphenyl)-benzamide in Rat Serum and Urine

Abstract

The compound 4-amino-N-(2,6-dimethylphenyl)-benzamide has shown potential as a new anticonvulsant. A method for the liquid chromatographic determination of serum and urine concentrations of the compound and its N-acetylated metabolite was developed for pharmacokinetic studies. Quantitation was achieved via UV detection at 275 nm following isocratic reversed phase (C₁₈) separation using a ternary solvent system of water:acetonitrile:acetic acid (60:39:1) at a flow rate of 1.5 mL/min. The compounds were isolated from a 50 μL sample of serum using solid phase extraction with prior protein precipitation. The compounds and internal standard were eluted from the extraction column with acetonitrile. Isolation from urine was achieved similarly with the exclusion of protein precipitation. The assay procedure is useful for the determination of concentrations of parent compound from 0.68 to 204.6 μg/mL.     

An Improved HPLC Method for the Determination of Furosemide in Plasma and Urine

Abstract

A sensitive HPLC method with minimal sample preparation and good reproducibility for the determination of furosemide in plasma and urine is described. Acidified plasma samples were extracted using CH₂Cl₂ containing desmethylnaproxen as internal standard (IS). Fresh urine samples were incubated with β-gluc-uronidase for 15 minutes and then treated with CH₃CN containing IS.

Chromatography was performed on a C18 column with 10 mcl sample injection, Mobile phases were: a) for plasma: 0.01 M NaH₂PO₄, pH 3.5 - CH₃OH (65:35), and b) for urine: acetic acid, pH 3.5 - CHS3OH (60:40) at 3 ml/min and fluorescence detection at Ex 235/Em 389 nm. The plasma standard curve was linear from 0.01 to 15.0 mcg/ml and the urine from 0.5 to 200.0 mcg/ml. The within run CV's were 3,2% at 0.74 mcg/ml plasma and 2.0% at 10.7 mcg/ml urine. Recovery from plasma was 69.9% at 2.0 mcg/ml and 98.6% from urine at 5.0 mcg/ml. The stability of furosemide and its glucuronide were studied. Both methods have been applied to the analysis of plasma and urine samples obtained from human volunteers.     

Quantitation of Creatinine in Urine and Plasma Samples by Reversed Phase HPLC

Abstract

Creatinine determination in urine and plasma affords an index of the renal function. Reversed-phase high pressure liquid chromatography was used for the separation and quantitation of creatinine in normal and arsenic exposed human urine samples. Acetonitrile/water (1:1) was the mobile phase. The method was compared with the Jaffé alkaline picrate reaction. Results show that the HPLC procedure has high reproducibility and samples are stable at the storage conditions. Plasma samples required depro-teinization and extraction with CH₃CN prior to HPLC analysis, while urine samples required only centrifugation.     

HPLC Separation of Theophylline,Paraxanthine, Theobromine,Caffeine and Other Caffeine Metabolites in Biological Fluids

Abstract

An HPLC method is described for rapid analysis of caffeine and seven of its metabolites in plasma, urine, milk and saliva in a single operation using a 5 μ C₁₈ reverse phase column. The metabolites are extracted with chloroform - iso-propanol (85:15) from 100 μL samples added to NH₄HCO₃. No interference from normal blood, urine, milk or saliva constituents was observed. The method is accurate and precise and separates 1,7-dimethylxanthine (paraxanthine) from 1,3-dimethylxanthine (theophylline). Sensitivity for most metabolites is in the range of 0.1 to 0.3 μg/mL and the detectability is at the nanogram level.     

HPLC Separation of Sugar Anomers in a Very Low Temperature Region

Abstract

High-performance liquid chromatographic (HPLC) separation of sugar anomers was carried out on -NH₂ columns in acidic eluents in a very low temperature region. Chromatogram patterns were found to show remarkable changes with decreasing column temperatures. This was attributed to the fact that interconversion between sugar anomers (mutarotation) occurred during the chromatographic process. Since mutarotation was suppressed in a very low temperature region, pyranose anomers of each mono- and di-saccharide were separated completely. Furanose anomers were also separated from an equilibrium mixture, and the necessary conditions for complete separation of furanose anomers were discussed.     

Separation of Xanthine Derivates by High Pressure Liquid Chromatography and Application to Plasma Analysis

Abstract

High pressure liquid chromatography (HPLC) methods were developed for separation and plasma analysis of ten xanthine derivates. Separation was evaluated on silica column and on three different reverse phase columns, with optimum conditions obtained on C₆ spherisorb column using isocratic elution with phosphate buffer 10^?2 M, pH 2.7 - acetonitrile mixture (80/20 V/V). Determination of these xanthine derivates in plasma for therapeutic control was studied.     

Separation of phenolic compounds and corresponding glucuronides by coupled-column micellar reversed-phase liquid chromatography

Summary An isocratic HPLC technique for separation of phenolic compounds and corresponding glucuronides in urine is developed. Sample pre-treatment, often a tedious and rate-limiting factor, was eliminated by use of a coupled column system. Spiked urine samples were injected directly into a C₄ precolumn and a selected fraction was transferred on-line from the precolumn to a silanized C₁₈ analytical column in the backflush mode. Analyte peak enrichment was attained by employing mobile phases of different elution strengths. The weaker mobile phase (7% v/v acetonitrile) was used to strongly retain the analytes on the precolumn while most of the polar endogenous compounds were washed to waste. Elution and transfer of the trapped analytes from the precolumn to the analytical column was achieved by introducing a stronger mobile phase (20% v/v acetonitrile) with the aid of a switching valve. The use of cetyltrimethylammonium bromide as counter ion and micellar agent in the mobile phase involved a high selectivity for the analytes relative to the urine matrix components and allowed simultaneous analysis of the glucuronides and parent compounds without the need of gradient elution. The system demonstrated a good repeatability on spiked urine samples. Who passed away July 21, 1996     

A New Method for the HPLC Analysis of Pt(II) in Urine

Abstract

An analytical method has been developed to measure Pt(II) in urine via derivatization and UV or HPLC analysis. A measured quantity of urine is heated briefly with diethyl ammonium diethyl-dithiocarbamate, and the resulting Pt(Et₂NCS₂)₂ is extracted into a measured volume of chloroform. Concentrations of Pt(II) are determined by UV absorption at 346 nm or by reverse phase HPLC analysis. The detection limit for Pt(II) as its dithiocarbamate is ～ 1 ng by HPLC; the concentration limit for HPLC analysis by direct extraction was ～ 25 ng/ml. Chromatographic response was linearly related to Pt(II) concentration over the range 100-4, 000 ng/ml; dilution of more concentrated samples has extended this range to at least 30, 000 ng/ml. This method has been applied to the analysis of Pt(II) in the urine of patients who have received cis-dichlorodiamniineplatinum(II) (CDDP) chemotherapy.     

A Simple High Performance Liquid Chromatography Procedure for the Determination of N1-Methylnicotinamide in Urine

Abstract

A simple high performance liquid chromatography procedure for the determination of N¹-methylnicotinamide in urine samples is described. The procedure eliminates the need for extraction or ion exchange clean-up of urine samples prior to their analysis. Human and rat urine samples can be analyzed for N¹-methylnicotinamide directly following a simple pH adjustment. The metabolite was separated and quantitated on a 5μ Ultrasphere ODS (C18) reverse-phase column. The mobile phase contained 10 mM K₂HPO₄ and 10 mM sodium 1-octanesulfonate in 8% acetonitrile at pH 7.0. The system has been used to conduct over 1000 determinations during a period of three months without reduction in performance or efficiency.     

Evaluation of Monolithic Columns for Determination of Formaldehyde and Acetaldehyde in Sugar Cane Spirits by High-Performance Liquid Chromatography

Abstract

High-Performance Liquid Chromatography (HPLC) conditions are described for separation of 2,4-dinitrophenylhydrazone (2,4-DNPH) derivatives of carbonyl compounds in a 10 cm long C₁₈ reversed phase monolithic column. Using a linear gradient from 40 to 77% acetonitrile (acetonitrile-water system), the separation was achieved in about 10 min—a time significantly shorter than that obtained with a packed particles column. The method was applied for determination of formaldehyde and acetaldehyde in Brazilian sugar cane spirits. The linear dynamic range was between 30 and 600 µg L^?1, and the detection limits were 8 and 4 µg L^?1 for formaldehyde and acetaldehyde, respectively.     

High Performance Liquid Chromatogrphy of Fat-Soluble Vitamins. III. Determination of Vitamin D3 in Pharmaceutical Preparations and in Blood

Abstract

A reversed phase high-performance liquid chromatographic method (HPLC) is described for separation and determination of colecalciferol (Vitamin D₃) in Vitamin preparations and in biological materials. Vitamin D₃ is extracted from the formulations and from the blood in a fully automated electronically controlled extraction apparatus. For HPLC a column of lichrosorb RP18 and methanol as eluent are used. The extraction, separation and determination of vitamin D₃ needs about 10–20 minutes. The described extraction and HPLC methods allow the detection of 1–2 ng per injection and are well reproduced with a maximum coefficient of variation of < 3,5%. Vitamin A-acetate is used as internal standard.     

A Simple Liquid Chromatographic Method for Analysis and Isolation of the Unsaturated Components of Anacardic Acid

Abstract

Good analytical and preparative separation of the saturated, monoene, diene and triene components of anacardic acid have been achieved by reverse phase HPLC on a C₁₈ column by isocratic elution with methanol-aqueous acetic acid.     

Separation of a Homologous Series of Long-Chain Fatty Alcohols (C49-C58) From Mycobacterium Tuberculosis H37Ra by High Performance Liquid Chromatography

Abstract

Fatty alcohols were obtained from the saponified chloro-form-methanol extract of Mycobacterium tuberculosis H37Ra by extraction with diethyl ether and partially purified by silicic acid column chromatography. The long-chain fatty alcohols (C₄₉-C₅₈) were separated from the shorter-chain alcohols by Sephadex LH-20 column chromatography and further fractionated into saturated and unsaturated alcohols by argentation thin-layer chromatography. These two fractions were analyzed by proton nuclear magnetic resonance spectro-scopy, derivatized to the 3,5-dinitrobenzoyl esters, and fractionated on a C₁₈-bonded silica column by high performance liquid chromatography (HPLC). Complete separation of esters differing by two carbon units and partial separation     

HPLC Analysis of Oligomeric Ethylene Glyccl Mixtures Via bis(2,4-Dinitrophenylation)

Abstract

Bis(2,4-dinitrophenylation) of oligomeric ethylene glycols of the formula HO-(CH₂CH₂O)_n-H (n=4–16)to the corresponding DNP-C(CH₂CH₂-O) -DNP (where DNP stands for 2,4-dinitrophenyl) provides chromophoric derivatives, which are separated chromatographically on HPLC column.

The bis(2,4-dinitrophenyl) glycols are stable in presence of triethylamine, but undergo ethanolysis in presence of hydroxide ions. The quantitative removal of the DNP groups allows an integrated scheme to pure glycols from commercially available polyethylene glycol mixtures, by bis(2,4-dinitrophenylation), chromatographic separation, end-group removal, using HPLC of the bis-(2,4-dinitrophenyl) glycols for purity monitoring.     

High Performance Liquid Chromato-Graphy Separations of Nitrosamines. II. Acyclic Nitrosamines

Abstract

The separation of acyclic nitrosamines by HPLC using a β-cyclodextrin bonded silien gel column and a C₁₈ reversed phase column was evaluated. Four groups of nitrosamines were used to evaluate the utility of both columns: (1.) methylmethyl-, methylethyl-, methylpropyl and methylbutyl-; (2.) ethylmethyl-, ethylethyl-, and ethylpropyl-; (3.) propylmethyl-, propylpropyl-, and propylbutyl-; and (4.) butylmethyl-, butylethyl-, butylpropyl-, and butylbutyl nitrosamines.

The results show that both columns performed well in separating the nitrosamines in each group, with the C₁₈ column requiring a higher percentage of organic modifier (methanol) than the β-cyclodextrin column. The β-cyclodextrin column was superior in separating all the E to Z isomers of short chain alkyl nitrosamines, while the C₁₈ column was superior in separating long alkyl chain nitrosamines and their E and Z isomers.

It, was also found that, the longer the alkyl chain the longer the retention time, while nitrosamines having the same number of carbons, for example ethylbutyl-and propylpropyleluted at virtually the same time, using both columns.